Asthma Research
Asthma is a common chronic inflammatory disease of the respiratory system that affects approximately 22 million people in US. It has been classified as a complex genetic condition that is determined by the interaction of numerous genes along with environmental factors.
Asthma Research Products Targets
Products for Asthma Research - Page 4
- Cat.No. Product Name Information/Activity
-
BCC7446
UCL 2077
UCL 2077 is a selective slow-afterhyperpolarization (sAHP) channel blocker (IC50 = 500 nM in hippocampal neurons in culture), having minimal effects on Ca2+ channels, action potentials, input resistance and the medium after hyperpolarization. UCL 2077 is also a subtype-selective blocker of the epilepsy associated KCNQ channels.
-
BCC5812
AF 12198
Potent, selective human type I IL-1 receptor antagonist
-
BCC7149
YM 90709
YM-90709 is a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor.
-
BCC5895
Lyn peptide inhibitor
222018-18-0
-
BCC5813
Ro 26-4550 trifluoroacetate
1217448-66-2
-
BCC6223
ACHP
406208-42-2
-
BCC1423
BMS-345541
BMS-345541 hydrochloride is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541 binds at an allosteric site of IKK.
-
BCC6130
PF 184
1187460-81-6
-
BCC7949
PS 1145 dihydrochloride
1049743-58-9
-
BCC4554
SC-514
SC-514 is a selective IKK-2 inhibitor (IC50=11.2 μM), which does not inhibit other IKK isoforms or other serine-threonine and tyrosine kinases.
